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ABSTRACT Emerging zoonotic viral diseases remain a challenge to global public 
health. Recent surveillance studies have implicated bats as potential reservoirs for a 
number of viral pathogens, including coronaviruses and Ebola viruses. Caliciviridae 
represent a major viral family contributing to emerging diseases in both human and 
animal populations and have been recently identified in bats. In this study, we 
blended metagenomics, phylogenetics, homology modeling, and in vitro assays to 
characterize two novel bat calicivirus (BtCalV) capsid sequences, corresponding to 
strain BtCalV/A10/USA/2009, identified in Perimyotis subflavus near Little Orleans, MD, 
and bat norovirus. We observed that bat norovirus formed virus-like particles and 
had epitopes and receptor-binding patterns similar to those of human noroviruses. 
To determine whether these observations stretch across multiple bat caliciviruses, 
we characterized a novel bat calicivirus, BtCalV/A10/USA/2009. Phylogenetic analysis 
revealed that BtCalV/A10/USA/2009 likely represents a novel Caliciviridae genus and 
is most closely related to recoviruses. Homology modeling revealed that the capsid 
sequences of BtCalV/A10/USA/2009 and bat norovirus resembled human norovirus 
capsid sequences and retained host ligand binding within the receptor-binding 
domains similar to that seen with human noroviruses. Both caliciviruses bound histo-
blood group antigens in patterns that overlapped those seen with human and ani-
mal noroviruses. Taken together, our results indicate the potential for bat calicivi-
ruses to bind histo-blood group antigens and overcome a significant barrier to 
cross-species transmission. Additionally, we have shown that bat norovirus maintains 
antigenic epitopes similar to those seen with human noroviruses, providing further 
evidence of evolutionary descent. Our results reiterate the importance of surveil-
lance of wild-animal populations, especially of bats, for novel viral pathogens.
IMPORTANCE Caliciviruses are rapidly evolving viruses that cause pandemic out-
breaks associated with significant morbidity and mortality globally. The animal reser-
voirs for human caliciviruses are unknown; bats represent critical reservoir species 
for several emerging and zoonotic diseases. Recent reports have identified several 
bat caliciviruses but have not characterized biological functions associated with dis-
ease risk, including their potential emergence in other mammalian populations. In 
this report, we identified a novel bat calicivirus that is most closely related to non-
human primate caliciviruses. Using this new bat calicivirus and a second norovirus-
like bat calicivirus capsid gene sequence, we generated virus-like particles that have 
host carbohydrate ligand binding patterns similar to those of human and animal no-
roviruses and that share antigens with human noroviruses. The similarities to human
Zoonotic diseases remain among the greatest overall threats to global public health.Current estimates indicate that 70% of all new emerging infectious diseases are of
noroviruses with respect to binding patterns and antigenic epitopes illustrate the 
potential for bat caliciviruses to emerge in other species and the importance of 
pathogen surveillance in wild-animal populations.
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zoonotic origin (1, 2). Historical examples of zoonotic pathogens include avian and 
swine influenza viruses, henipaviruses, and severe acute respiratory syndrome corona-
virus (SARS-CoV). More recently, the emergence of Ebola virus and of Middle East 
respiratory syndrome coronavirus (MERS-CoV) has resulted in local and intercontinental 
pandemics, with animal reservoirs believed to play a critical role in their emergence 
(3–6). Bats, which are among the most common reservoirs for these zoonotic patho-
gens, have been identified as reservoirs or potential reservoirs for a number of highly 
pathogenic viruses, including SARS-CoV (7–9), MERS-CoV (10), and Ebola virus (4). A 
recent study of the viral diversity within Pteropus giganteus identified 55 viruses 
spanning nine viral families. The authors extrapolated these findings to estimate that a 
minimum of 320,000 unknown viruses are currently circulating among wild-mammal 
populations globally (11). Nevertheless, the prevalence of viruses in wild mammals, 
particularly among bats, remains grossly understudied. Thus, the surveillance of local 
and global bat populations can help identify potentially zoonotic or pandemic patho-
gens prior to their emergence.
The Caliciviridae family consists of nonenveloped, positive-sense RNA viruses sub-
classified into five genera, Vesivirus, Lagovirus, Norovirus, Sapovirus, and Nebovirus, along 
with two unclassified genera, Recovirus and Valovirus. Caliciviruses infect a wide 
range of hosts, including humans and wildlife and domestic, companion, and agricul-
tural animals, although the origins and radiation of these viruses through mammalian 
populations remain uncertain. For instance, the Norovirus genus, which contains the 
most common and well-known caliciviruses, consists of six genogroups and has an 
expansive host range. Primarily identified in humans, noroviruses (NoVs) have also been 
identified in canine (12–14), feline (14, 15), swine (16, 17), murine (18, 19), ovine (20), 
and bovine (21) species. Other caliciviruses have been identified in sea lions (22–24), 
minks (25), rabbits (26, 27), chickens (28), geese (29, 30), fish (31), and nonhuman 
primates (32, 33), indicating the broad host range of the Caliciviridae.
The mechanisms by which the caliciviruses have expanded their host range and 
emerged to infect the human population are currently unknown. Some human noro-
viruses (HuNoVs), the most well-known and prevalent caliciviruses, undergo epochal 
evolution, with a new pandemic strain emerging every 2 to 5 years (34); new strains 
emerge following herd immunity-induced evolution within antigenic and receptor 
binding epitopes (35). The immunocompromised human population might also serve 
as a reservoir from which pandemic noroviruses might emerge, while zoonotic trans-
mission remains likely but unsubstantiated (36–39). However, antibodies against animal 
caliciviruses have been detected in the human population, suggesting the potential for 
cross-species transmission events, though clinical disease has yet to be confirmed 
(40–44). Thus, the identification and study of animal caliciviruses, including bat calici-
viruses (BtCalVs), and their potential role in zoonotic disease and cross-species trans-
mission potential represent significant gaps in global health preparedness.
Several recent reports have identified Caliciviridae sequences resident within several 
different bat species worldwide (45–50). Phylogenetic analyses have revealed that 
these viruses are closely related to sapoviruses (45, 46, 49) and valoviruses (46). More 
importantly, bat noroviruses have been reported in two separate studies of microbats 
in China (50, 51), including one nearly full-length Norovirus genome (here referred to 
as bat norovirus [BtNoV]) (50). However, in the absence of any biological data, the 
potential of these viruses to transmit into other mammals, including humans, is difficult
FIG 1 BtNoV VLPs share antigenic epitopes with HuNoVs. (A) We generated VLPs for BtNoV using the VEE replicon in BHK cells. BtNoV
VLPs had sizes and morphologies similar to those of GII.4.Lordsdale.1997 HuNoV VLPs. (B and C) GI (left panels) and GII.4 (right panels)
HuNoV hyperimmune serums were used to determine antigenic relationships between BtNoV and HuNoV (GI.1.Norwalk.1968,
GII.4.Lordsdale.1997, GII.4.Sydney.2012) VLPs. (B) Data presented are the mean absorbance values (optical density at 450 nm [OD450])
measured following subtraction of negative-control absorbance values  SEM for GI serum and GII.4 serum. (C) Mean EC50  SEM
(1/serum dilution) for reactivity of each antibody with each VLP. Each panel is representative of results from two independent experiments
conducted in duplicate. *, VLP with EC50 value significantly different from EC50 of BtNoV (one-way ANOVA, P  0.05).
to predict from genome-length sequences. These reports of novel caliciviruses identi-
fied in bats not only stress the need for surveillance but also emphasize the need for 
detailed biological and immunologic characterization of new caliciviruses identified in 
wild-animal populations, particularly bats, to provide potential insights into cross-
species transmission potential and human health.
Here, we evaluate the antigenicity and receptor-binding profiles of two bat calici-
viruses. Specifically, we generated virus-like particles (VLPs) from the BtNoV capsid 
sequence (50) that were detected with HuNoV-derived hyperimmune serums, indicat-
ing antigenic relationships shared between HuNoVs and BtNoV. Further, we character-
ize a novel bat calicivirus capsid sequence isolated from Perimyotis subflavus, the 
tri-colored bat, in the Mid-Atlantic region of the United States (52). Phylogenetic 
analyses revealed that this bat capsid sequence likely represents a novel calicivirus that 
is most closely related to non-human caliciviruses, such as lagoviruses and recovi-
ruses. We used VLPs from the newly identified bat calicivirus and BtNoV to assess their 
potential carbohydrate patterns in comparison with those of human noroviruses. Here, 
we describe host carbohydrate ligand-receptor binding patterns that overlapped be-
tween bat and human caliciviruses, suggesting that bat caliciviruses have the poten-
tial to clear one barrier to cross-species movement. Our data also suggest that bat 
caliciviruses share antigenic epitopes with HuNoVs, indicating a potential linkage via 
evolutionary descent.
RESULTS
BtNoV is antigenically similar to HuNoVs. We first sought to identify if BtNoV 
maintained any antigenic similarity with noroviruses, specifically HuNoVs. Thus, we 
produced BtNoV VLPs using alphavirus replicon vectors in BHK cells. The BtNoV capsid 
sequence formed VLPs of approximately 40 nm in diameter that resembled VLPs 
generated from genotype II 4.1997.Lordsdale (GII.4.1997.Lordsdale) HuNoV (Fig. 1A). To
FIG 2 BtNoV VLPs bind to HBGAs in a temperature-dependent manner similar to that seen with GII.4.Lordsdale.1997
HuNoV VLPs. We evaluated interactions between GII.4.Lordsdale.1997 HuNoV VLPs (left) and BtNoV VLPs (right) against
Hs1, Hs3, A, and B HBGAs and -2,6 sialic acids under a gradient of physiological conditions. Data presented are mean
OD450 absorbance values following subtraction of negative-control absorbance  SEM. Each VLP-HBGA interaction was
evaluated in duplicate in two independent experiments. *, VLP-HBGA at 32°C and 37°C with a mean OD450 absorbance
value significantly different from the mean absorbance value at 25°C (two-way ANOVA, P  0.05).
discern the potential antigenic relationships of BtNoV with HuNoVs, we utilized an 
enzyme immunoassay (EIA) (53) with hyperimmune serums against GI or GII.4 HuNoVs 
and against VLPs from BtNoV and a panel of GI and GII.4 HuNoVs (Fig. 1B and C).
As anticipated, hyperimmune GI and GII.4 HuNoV-derived serums strongly reacted 
with their homotypic VLPs (Fig. 1B). Specifically, GI.1.Norwalk.1968 HuNoV VLPs reacted 
strongly with the homotypic GI HuNoV hyperimmune serums (Fig. 1C) (50% effective 
concentration [EC50] of 1/71,456); similarly, both GII.4.Lordsdale.1997 and GII.4.Sydney. 
2012 HuNoV VLPs reacted strongly with the homotypic GII.4 HuNoV hyperimmune
serums (EC50s of 1/104,962 and 1/5,984, respectively) (Fig. 1C). Interestingly, BtNoV VLPs
reacted with both GI and GII.4 serums similarly to the VLPs derived from heterotypic 
HuNoVs (Fig. 1B). The BtNoV VLPs required significantly higher levels of GI (EC50 of 
1/340.4) and GII.4 (EC50 of 1/694.4) serums than the homotypic VLPs for detection by 
EIA. It is noteworthy that the BtNoV and GII.4.Sydney.2012 VLPs had almost identical
EC50s for binding GI HuNoV-derived serums.
BtNoV binds histo-blood group antigens similarly to a historic HuNoV. Since we 
had established that BtNoV VLPs are antigenically similar to HuNoV-derived VLPs and 
since host receptor ligand differences are among the primary barriers to calicivirus 
cross-species transmission, we next sought to identify whether BtNoV VLPs could bind 
histo-blood group antigens (HBGAs) in vitro. Additionally, as bats are heterothermic, 
their body temperatures fluctuate from ambient temperature during torpor to 37°C 
during their active state (54, 55). Further, temperature changes have been shown to 
induce conformational changes in the HuNoV capsid, altering the presentation of 
antigenic epitopes (56). Thus, we hypothesized that temperature changes would 
impact these potential VLP-carbohydrate ligand binding interactions (Fig. 2). To address 
these issues, we utilized an in vitro synthetic HBGA carbohydrate binding assay and 
incubated the BtNoV VLPs in comparison with GII.4.Lordsdale.1997 HuNoV VLPs at a 
gradient of temperatures that capture a range of physiological temperatures identified 
in bats: 25°C, 32°C, and 37°C.
As we hypothesized, BtNoV VLPs bound to HBGAs and their carbohydrate binding 
interactions were impacted by temperature in a manner similar to that seen with 
HuNoVs (Fig. 2). Specifically, GII.4.Lordsdale.1997 VLPs bound significantly better to A 
type HBGA at 32°C and 37°C and -2,6-sialic acid at 37°C. A similar trend, though the 
data were not statistically significant, was observed with these VLPs with respect to H 
type 1 HBGAs. Similarly, the BtNoV VLPs bound significantly better to H type 1 and A 
at 37°C and -2,6-sialic acid at 32°C and 37°C. We noted no trends with respect to 
correlations between incubation temperature and the binding of either VLP to H type 
3 or B HBGAs, though BtNoV VLPs did not bind to these HBGAs as well as HuNoV-
derived VLPs. These results indicate that the temperature may induce conformational 
changes within the BtNoV capsid similarly to HuNoVs (56), that the transmission of
FIG 3 Identification of a novel North American bat viral sequence that is phylogenetically related to Caliciviridae. We identified a sequence from Perimyotis
subflavus that was related to Caliciviridae capsid sequences. (A) The distribution of P. subflavus throughout North America and Central America is marked in red.
The sampling site of Little Orleans, MD, is marked by a star (inset). The map was generated using data from the International Union for Conservation of Nature
(IUCN) with permission. (B and C) A maximum-likelihood cladogram (B) and radial phylograms (C) of 51 known calicivirus S domain amino acid sequences were
generated based on the JTT matrix-based amino acid substitution model (SB) and the Jukes-Cantor genetic distance model (SC). BtNoV and BtCalV/A10 are
indicated by yellow and blue arrows, respectively.
these bat viruses may depend on the activity level and body temperature of bats, and 
that bats may carry or transmit HBGA-binding viruses under a gradient of physiological 
conditions.
The A10 bat calicivirus is phylogenetically related to recoviruses. We next 
hypothesized that other caliciviruses are circulating in bats and, similarly to our 
observations with BtNoV, would be capable of binding HBGAs in vitro. In a previous 
report, we identified multiple viral sequences from Coronaviridae, Herpesviridae, Iflaviri-
dae insect viruses, Tymoviridae plant viruses, and Podoviridae bacteriophage in sev-
eral species of bats near an abandoned railway tunnel (Indigo Tunnel) in Allegany 
County, MD, USA, approximately 1 mi east of Little Orleans, MD (Fig. 3A) (52). Addi-
tionally, we assembled two contigs of 865 nucleotides and 534 nucleotides from 232 
and 3 sequence reads from the guano of Perimyotis subflavus, the tri-colored bat. A 
BLAST search showed that the assembled contigs most closely matched the capsid
recoviruses but likely belongs to a novel genus within Caliciviridae. Conversely, BtNoV
clustered with murine norovirus (MNV) and rooted a clade of viruses that included
BtCalV/A10, the animal caliciviruses, and GI and GIII noroviruses. While BtCalV/A10
clustered most closely with RHDV and next most closely with the recoviruses, it
maintained only 22% sequence identity and 19% to 22% sequence identity with those
viruses, respectively (see Table S1 in the supplemental material). Conversely, BtNoV
maintained 60% amino acid sequence identity with its closest relative, MNV, and only
23% similarity with BtCalV/A10. Similar phylogenetic relationships were observed in
VP1 analysis (see Fig. S1 in the supplemental material). Taken together, our phyloge-
netic results suggest that BtCalV/A10 most likely represents a genus and species
distinct from all of the previously identified caliciviruses; in contrast, based on accepted
norovirus classifications (59), BtNoV likely belongs to genogroup V (GV) with MNV.
sequences of GII HuNoVs and feline calicivirus, indicating the identification of a 
510-amino-acid capsid sequence (GenBank accession number MH259583) of a bat 
calicivirus, BtCalV/A10/USA/2009 (here referred to as A10 bat calicivirus [BtCalV/A10]). 
It is noteworthy that we did not identify similar calicivirus sequences from the other 
sampled bat species.
To identify how BtCalV/A10 and BtNoV are related to known Caliciviridae capsid 
sequences, we analyzed the amino acid sequences of the conserved shell (S) domain of 
the capsid protein due to the extensive variability within the protruding domain of the 
VP1 capsid protein (57, 58). We generated S domain phylogenetic trees and cladograms 
from 51 known calicivirus S domain sequences (Fig. 3B and C). First, we noted that 
BtNoV and BtCalV/A10 clustered in separate clades. BtCalV/A10 was directly rooted by 
the nonhuman primate recoviruses and further rooted a clade containing lagoviruses, 
human and animal sapoviruses, vesiviruses, and neboviruses. Based on this analysis, 
BtCalV/A10 is most closely related to rabbit hemorrhagic disease virus (RHDV) and the
Homology modeling of BtCalV/A10 and BtNoV using HuNoVs and MNV. Previ-
ous works have solved the capsid and P domain structures of several caliciviruses (60, 
61). To determine how the BtCalV/A10 and BtNoV capsids structurally compare to 
known human and animal norovirus capsids, we utilized predictive structural modeling 
to illustrate the full-length BtCalV/A10 and BtNoV capsid structures. First, we used 
PHYRE2 open source software to determine if BtCalV/A10 contained known calicivirus 
capsid structures followed by structural homology modeling using Modeller software 
from the Max Planck Institute Bioinformatics Toolkit (62–64). Due to its low amino acid 
similarity to known calicivirus sequences, we also modeled the BtCalV/A10 sequence 
using HuNoVs (PDB identifiers [IDs]: 2OBT and 4WZT) and MNV (PDB ID: 3LQE) as  
backbones to capture multiple potential structures and predict potential sites of HBGA 
binding (see Fig. 5).
As expected, the PHYRE2 software predicted the structure of several calicivirus 
full-length capsids, including GII.4.1997.Lordsdale HuNoV, MNV, GI.1 human sapovirus, 
and BtNoV (Fig. 4A), supporting the use of PHYRE2 software for predictive homology 
modeling. These models folded into distinct structures similar to previously reported 
calicivirus structures (Fig. 4A), including -sheets in the S domain and P2 subdomains 
(46). Conversely, PHYRE2 determined that the BtCalV/A10 capsid formed distinct S and 
P2 subdomains similar to those of other caliciviruses but contained extensive disorder 
and unpredictability within the P1 subdomain, which corresponds with the capsid 
sequence size of BtCalV/A10 being smaller than that seen with other caliciviruses. While 
the predicted BtCalV/A10 structure contained -sheets in the S domain similar to those 
seen with the other calicivirus structures (Fig. 4A), we also observed several -helices 
within the P2 subdomain rather than the -sheets observed in known calicivirus 
structures. The predictive modeling by PHYRE2 suggested two conclusions: the pres-
ence of -sheets in the S domain suggested that the BtCalV/A10 capsid sequence 
resembled a calicivirus capsid sequence, but the unrecognized structures in P1 and 
-helices in P2 suggested that BtCalV/A10 contained novel structures dissimilar from
the structures in other caliciviruses, further supporting its tentative placement as a
novel genus within Caliciviridae.
FIG 4 Bat caliciviruses retain host ligand binding sites similar to those of HuNoVs. (A) Modeling of full-length VP1 capsid sequence
from HuNoV, MNV, GI.1 human sapovirus, BtNoV, and BtCalV/A10 using the PHYRE2 Protein Recognition Server. MNV (B) and GII.4
HuNoVs (E) were used as backbones for predictive homology modeling with Modeller software from the Max Planck Institute. The
P dimers of BtCalV/A10 were modeled from MNV (C) and GII.4 HuNoVs (F). The P dimers of BtNoV were modeled from MNV (D)
and GII.4 HuNoVs (G). In panels E to G, ligand binding sites were predicted by the 3DLigandSite and are marked in red. (E to G)
Type A trisaccharide HBGA is indicated by white spheres.
As the PHYRE2 modeling software did not fully predict the structure of the BtCalV/
A10 capsid protein, we next modeled the BtCalV/A10 and BtNoV P dimers from the 
most closely related animal norovirus, MNV (Fig. 4B to D). Alignment of the P domains 
revealed that the BtCalV/A10 sequence had four insertions within the P domain 
compared to the MNV P domain template; similarly, the BtNoV sequence contained 
three insertions and three deletions compared to MNV (data not shown). However, as 
expected, the homologous models for both BtCalV/A10 (Fig. 4C) and BtNoV (Fig. 4D) 
resembled the MNV P domain backbone (Fig. 4B).
We also modeled the BtCalV/A10 and BtNoV P dimers on the backbone of two GII.4 
HuNoVs (Fig. 4E to G). Compared to the HuNoV sequences, the BtCalV/A10 P domain 
sequence had six insertions and four deletions, while the BtNoV P domain sequence 
had three insertions and five deletions (data not shown). These modifications did not 
affect modeling of the P dimers from HuNoVs for either of the bat virus sequences. The 
BtCalV/A10 dimer (Fig. 4F) and BtNoV dimer (Fig. 4G) each resembled the P dimers of 
their HuNoV counterparts (Fig. 4E). Additionally, the open source software 3DLigand-
Site (65) indicated that the models retained ligand binding sites (red) for type A HBGAs 
(white spheres) similar to those seen with the GII.4 HuNoV backbone.
BtCalV/A10 and BtNoV have different HBGA carbohydrate binding profiles, but 
both resemble HuNoV with respect to binding patterns. As we had shown that 
BtNoV VLPs could bind HBGAs (Fig. 2), we sought to identify whether the phylogeneti-
cally unrelated BtCalV/A10 shared similar host receptor ligand binding interactions.
FIG 5 Bat caliciviruses retain HBGA binding patterns overlapping those of HuNoV VLPs. VLPs for BtCalV/A10 were generated using the VEE replicon in C6/36
cells. (A) The HBGA binding patterns of BtCalV/A10 and BtNoV were screened in comparison with those of HuNoVs (GI.1.Norwalk.1968, GII.4.1997.Lordsdale, and
GII.4.Sydney.2012). The data presented are mean absorbance values (OD450) following subtraction of negative-control values  SEM. Each VLP-HBGA interaction
was measured in duplicate in two independent experiments. (B) Caliciviruses bind HBGAs, sialic acids, and other host ligands. Virus-ligand interactions were
included in the Venn diagram for cases in which one publication had reported binding to the host ligand.
Thus, we utilized a synthetic carbohydrate binding assay to identify the potential HBGA 
receptor-binding patterns of BtCalV/A10 in comparison with a panel of VLPs derived 
from several HuNoVs (GI.1.Norwalk.1968, GII.4.Lordsdale.1997, and GII.4.Sydney.2012) 
and BtNoV (Fig. 5A).
Among the HuNoVs, GI.1.Norwalk.1968 VLPs primarily bound H type 3 and A 
antigens but weakly bound the H type 1 and B antigens and -2,6-sialic acid. Con-
versely, GII.4.Lordsdale.1997 VLPs strongly bound H type 3, A, and B and -2,6-sialic 
acid, with limited binding to H type 1. GII.4.Sydney.2012 VLPs displayed weak binding 
to all carbohydrates but bound most strongly to the A antigen. BtCalV/A10 VLPs bound 
strongly to A, B, and H type 3 HBGA carbohydrates but bound weakly to H type 1 and 
-2,6-sialic acid. Of note, BtCalV/A10 VLPs bound strongly to the H type 3 and A HBGAs 
at a magnitude similar to that seen with the GII.4.Lordsdale.1997 HuNoV VLPs. Con-
versely, the BtNoV VLPs again bound to -2,6-sialic acid but displayed modest binding 
to the H type 1 and H type 3, A, and B HBGA carbohydrates, as we showed previously 
(Fig. 2). Each VLP in our panel displayed limited or weak binding to H type 2 antigen, 
Lewis antigens, or -2,3-sialic acid (data not shown). The bat caliciviruses exhibited 
different binding patterns: the BtCalV/A10 VLPs strongly bound H type 3, A, and B 
antigens, with limited binding to H type 1 and -2,6-sialic acids, while the BtNoV VLPs 
strongly bound -2,6-sialic acid, with moderate binding to H type 1 and H type 3, A, and 
B HBGAs, suggesting that bat caliciviruses can bind to a range of host receptors and 
offer multiple routes for cross-species transmission. Both of these binding patterns 
overlapped binding patterns that were previously reported for other animal calicivi-
ruses and HuNoVs (Fig. 5B). Our results, coupled with those previous reports, suggest 
that multiple routes of cross-species transmission exist among caliciviruses.
DISCUSSION
Bats are important reservoir hosts for newly emerging viruses, many with pandemic 
potential. The reservoir hosts for caliciviruses and noroviruses are presently unknown; 
the existence of distinct genera and genogroups, coupled with multiple variable 
genotypes, suggests that multiple novel independent introductions from animal pop-
ulations may have contributed to the genetic diversity of noroviruses and caliciviruses. 
Here, we reveal the potential for several bat caliciviruses to transmit across multiple 
species. Specifically, we found that a previously reported but uncharacterized virus, 
BtNoV (50), is antigenically similar to HuNoVs and can bind HBGAs in vitro. We built 
upon this finding through identification of a bat calicivirus sequence (BtCalV/A10) from 
P. subflavus near an abandoned railroad tunnel outside Little Orleans, MD. We further 
characterized both bat caliciviruses through phylogenetic analyses, predictive structural 
homology modeling, VLP production, and identification of VLP-HBGA binding patterns 
in vitro. Our report suggests that BtCalV/A10 is most closely related to RHDV, a highly 
virulent calicivirus that emerged suddenly in China from preexisting strains prior to 
spreading globally (66, 67). While more sequences are needed for clarification, A10 
likely represents a novel genus within Caliciviridae, while BtNoV likely belongs to GV 
with MNV. Structural homology modeling indicated that both bat viruses retain ligand 
binding sites similar to those seen with HuNoVs, validating their capability to bind 
HBGAs. The capsid sequences of both bat viruses formed VLPs similar to those formed 
by HuNoVs and showed overlapping HBGA binding profiles with respect to several 
HuNoVs and MNV. Importantly, as HBGAs are encoded across numerous animal species, 
particularly among mammals (68), similarities in attachment and entry cofactors sug-
gest that these bat viruses have the potential to overcome a major roadblock to 
cross-species transmission across a variety of mammalian species.
Metagenomic sequencing has illuminated the great diversity and complexity of RNA 
viruses distributed throughout the natural world. However, new strategies are desper-
ately needed to translate this information into meaningful predictions of biological 
processes, disease risk, and surveillance prioritization prior to epidemic or pandemic 
emergence. Previous studies on bat caliciviruses have focused on the use of phyloge-
netic analyses and structural modeling for classification of these novel viruses within 
the Caliciviridae family (45–49). While these techniques help contextualize viral relat-
edness within the framework of known and characterized viruses and their families, 
they do not necessarily aid in the understanding of biological functions or provide 
insight into the emergence potential of zoonotic pathogens. In this report, we utilized 
a novel platform combining metagenomics, phylogenetics, immunogenic comparisons, 
and homology modeling of two bat viruses; we showed that these viruses belong to 
Caliciviridae and are structurally similar to known human and animal caliciviruses. We 
coupled these data with in vitro techniques and immunologic assays to derive further 
relevant biological questions that can help to gauge the potential for cross-species 
transmission of two bat caliciviruses to other species prior to their emergence within 
the human population. A similar approach has identified the potential for MERS and 
SARS-like coronaviruses within Asian and African bat populations to replicate and 
emerge in human populations and to evade current therapeutics and has also identi-
fied bat coronaviruses that emerged more recently and caused outbreaks in swine (8, 
9, 69, 70).
Specifically, we showed that BtNoV VLPs maintain similarity to HuNoV VLPs with 
respect to antigenic and receptor-binding patterns (Fig. 1 and 2). Additionally, BtNoV 
VLPs bound HBGA receptors across a variety of temperatures similarly to HuNoVs 
(Fig. 2), indicating the potential for viral transmission under a variety of physiological 
conditions. Further, we utilized a second, unrelated bat calicivirus to demonstrate that 
these observations may be pertinent across multiple bat calicivirus species. For exam-
ple, BtCalV/A10 rooted a phylogenetic clade that included RHDV and recoviruses, 
which were the only viruses separating BtCalV/A10 from noroviruses (Fig. 3), but likely 
represents a novel genus within the Caliciviridae family. Next, we modeled the P 
domain structure of BtCalV/A10 and BtNoV and host carbohydrate receptor binding 
sites on their capsid structure similar to those seen with known HuNoV structures 
(Fig. 4). Finally, we observed that BtCalV/A10 also formed VLPs of similar sizes and 
structures that bound to several HBGAs and/or sialic acid moieties and displayed 
binding patterns that overlapped those of HuNoVs in vitro (Fig. 5A and B). However, 
despite the similarity in the predicted P domain structures, the bat viruses, similarly to
GI and GII HuNoVs, displayed disparate HBGA binding patterns, indicating multiple 
potential paths for cross-species transmission (Fig. 5B). Therefore, the utilization of the 
aforementioned platform identified antigenic relatedness of BtNoV and HuNoVs as well 
as the potential for cross-species transmission of two previously uncharacterized or 
unidentified bat caliciviruses.
Noroviruses have been historically classified on the basis of capsid sequence ho-
mology (59); based on this strategy, BtNoV would likely be classified within Norovirus 
GV alongside MNV. Enzyme immunoassays have been powerful tools for understanding 
antigenic relationships among noroviruses in spite of sequence homology, especially in 
elucidating how antigenic drift contributes to the evasion of herd immunity and 
emergence of novel HuNoV strains (35). In the present study, EIA performed with 
polyclonal serums derived from historic and current strains of HuNoVs showed that 
BtNoV VLPs are antigenically similar (Fig. 1) despite the parental virus’s phylogenetic 
relatedness to MNV (Fig. 3). Other bat noroviruses have shown extensive homology 
with GIV noroviruses (51), whose antibodies have been detected in humans and canine 
species (71, 72). These results further illustrate the importance of our proposed plat-
form: capsid sequence homology alone would not have predicted that bat caliciviruses 
could bind synthetic carbohydrates or be detected by serums against human viruses; 
in vitro assays revealed novel information regarding the caliciviruses circulating in bat 
populations.
The FUT2 gene, whose protein product promotes expression of HBGAs on mucosal 
surfaces, has a well-established role in HuNoV infection and RHDV disease (73–75). 
However, the receptors for animal caliciviruses are variable and less clear. For instance, 
GIII bovine noroviruses bind -galactose (76, 77), MNVs bind sialic acids and CD300lf 
(78–80), porcine sapoviruses bind sialic acids (81), and both feline calicivirus and the 
zoonotic San Miguel sea lion virus Hom-1 bind junctional adhesion molecule-1 (82, 83). 
While protein receptors seem quite variable, there is significant overlap in the identified 
carbohydrate binding patterns of all caliciviruses (Fig. 5), demonstrating multiple 
potential routes of cross-species transmission of these viruses.
Recent genomics analysis has further indicated the potential for animal caliciviruses, 
including bat caliciviruses, to cross species barriers. For instance, HBGAs have been 
identified or predicted across numerous animal species (68). Importantly, the A and B 
fucosyltransferase enzymes of Myotis lucifugus, a microbat similar to P. subflavus, 
contain amino acid sequences, amino acid motifs, and levels of phylogenetic related-
ness similar to those of their human orthologs (68). Similarly, CD300lf orthologs have 
been predicted in numerous animal species, including several Asian bats, such as 
Hipposideros armiger and Rhinolophus sinicus. In addition to CD300lf, sialic acids have 
previously been implicated as receptors or cellular cofactors for binding and entry by 
MNVs and, more recently, by HuNoVs (78, 84–86). Future studies will reveal whether the 
BtCalV/A10 or BtNoV VLPs also bind bat or mammalian CD300lf proteins. Though 
numerous factors mediate the cross-species transmission, replication, and pathogenesis 
of viruses, our results, coupled with those revealing the analogous host receptor 
structures, suggest that these bat caliciviruses have the potential to overcome host 
receptor barriers as a roadblock to cross-species transmission.
Our findings, along with previous reports (45, 46, 48–50), support the hypothesis 
that bats are a potential reservoir species for noroviruses and other caliciviruses, such 
as RHDV. While the BtCalV/A10 strain is very distant from RHDV, our data strongly 
suggest that more bat caliciviruses should be identified and sequenced, primarily in 
China, and that the results may reveal precursor strains that are more akin to this highly 
virulent pathogen of rabbits. The present study did not support the conclusion that bat 
caliciviruses will emerge in human or other mammalian populations but did suggest 
their potential for cross-species transmission. Our results further illustrate the impor-
tance of conducting continued surveillance of bat populations for viral pathogens prior 
to their emergence in human and other mammalian populations (11). If viral discovery 
is partnered with developing and answering meaningful biological questions to identify 
high-risk viral strains prior to epidemic or pandemic emergence, the cost of such
combined scientific investigations will pale in comparison to the cost of treatment and
eradication of these pathogens as they emerge in the human population.
MATERIALS AND METHODS
Viral genomic sequence isolation and identification. Viral genomic sequences were identified as 
part of a previous study (52). Briefly, bats were collected with harp traps at an abandoned railroad tunnel 
near Little Orleans, MD, and fresh guano was collected. Samples were stored on ice until processing. The 
BtCalV/A10 capsid sequence was isolated from Perimyotis subflavus (tri-colored bat) using the sequence-
independent single-primer amplification technique and 454 next-generation sequencing platform. De 
novo contigs were assembled using three programs: Codon Code Aligner, Geneious, and DNAStar. Viral 
amino acid sequences were created using Vector NTI. Assembled contigs were analyzed using the basic 
local alignment search tool (BLAST) from the National Center for Biotechnology Information (NCBI) (87). 
BLAST searches were conducted at the amino acid level using the protein-protein BLAST (blastp) function 
to query nonredundant protein sequences.
Phylogenetic analysis. Maximum-likelihood cladograms of 50 known calicivirus VP1 amino acid 
sequences and 51 known calicivirus S domain amino acid sequences were generated using MEGA7. The 
cladograms were generated based on the JTT matrix-based amino acid substitution model and initially 
derived with the Neighbor-Join (NJ) and BioNJ algorithms followed by pairwise distance estimation by 
the use of the JTT amino acid replacement model. Bootstrapping was conducted by generating 500 
bootstrapped replicates, and a consensus tree was developed using MEGA7. Consensus radial phylo-
grams were generated in Geneious R11, employing the same sequences used to construct the clado-
grams, with the Jukes-Cantor genetic distance model, the NJ build method, no outgroup, and 100 
bootstrap replicates. Phylograms were rendered for publication in Adobe Illustrator CC 2017.
Homology modeling. The full-length BtCalV/A10, GII.4.1997.Lordsdale HuNoV, GI.1 human sapovi-
rus, GV.1 MNV, and BtNoV capsid sequences (50) were submitted to the Protein Homology/analogy 
Recognition Engine V2.0 (PHYRE2) server (88) and analyzed using Intensive Mode. Homology modeling 
of the BtCalV/A10 and BtNoV sequences was based on the known HuNoV GII.4/VA387 (PDB ID: 2OBT) (89) 
and HuNoV GII.4.2012/NSW0514 bound to type A trisaccharide (PDB ID: 4WZT) (90) and MNV (PDB ID: 
3LQE) structures from the Protein Data Bank. The amino acid sequences were aligned using the Clustal 
Omega platform on the Bioinformatics Toolkit from the Max Planck Institute (62, 91). The predicted 
tertiary structure of the aligned sequence was determined by the use of the Modeller platform from the 
Bioinformatics Toolkit from the Max Planck Institute using GII.4.2012/NSW0514 as the template (63). 
Dimeric models were created using The PyMOL Molecular Graphics System, version 1.7.4.3 (Schrödinger, 
LLC).
Generation of virus-like particles. Virus-like particles (VLPs) were generated as previously described 
(92). Briefly, the BtCalV/A10 and BtNoV VP1 sequences were synthesized and inserted directly into the 
VEE 3526 replicon. VP1 mRNAs were derived via T7 polymerase in vitro transcription. The VEE-BtCalV/A10 
and VEE-BtNoV mRNAs were separately electroporated in C6/36 mosquito larva (Aedes albopictus) cells 
(ATCC) and BHK cells, respectively. Electroporated C6/36 and BHK cells were incubated at 32°C and 37°C, 
respectively, with 5% CO2 for 26 to 28 h before harvesting VLPs. VLPs were purified by velocity 
sedimentation in sucrose and concentrated in phosphate-buffered saline (PBS) using 100-molecular-
weight-cutoff (MWCO) centrifugal filter units (Millipore). VLP formation and structure were confirmed by 
transmission electron microscopy. Protein concentrations were determined by the use of the bicin-
choninic acid (BCA) protein assay (Pierce). VLPs for GI.1.Norwalk.1968, GII.4.1997.Lordsdale, and 
GII.4.Sydney.2012 HuNoVs and MNV were previously synthesized and stored at 80°C until use.
Carbohydrate binding assays. A carbohydrate binding assay to detect VLP binding was conducted 
as previously described (93, 94). Briefly, Costar enzyme immunoassay (EIA) plates (Corning) were coated 
with 2 g/ml of each of the produced VLPs mixed with PBS and incubated for 4 h at  room temperature. 
Plates were blocked overnight with blotto (5% instant dry milk–PBS–Tween 20). Synthetic biotinylated 
carbohydrates (Glycotech) diluted in blotto (10 g/ml) were added to each well and incubated at 37°C 
for 1 h. For the temperature-dependent HBGA binding assay, the plates were incubated at 25°C, 32°C, 
and 37°C for 1 h. Streptavidin-horseradish peroxidase (HRP) was diluted in blotto (1:10,000) and 
incubated at 37°C for 30 min. The plates were developed with One-Step Ultra-TMB (Thermo Fisher) for 
15 min and were stopped with 2 M H2SO4 prior to being read at 450 nm. Plates were washed 3 times 
with PBS– 0.05% Tween between steps. The following 11 carbohydrates were analyzed: H type 1, H type 
2, H type 3, A, B, Lewis A, Lewis B, Lexis X, Lewis Y, -2,3-sialic acid, and -2,6-sialic acid. PBS served as 
a negative control for VLP coating, and blotto served as a negative control for HBGA binding. Each 
HBGA-VLP interaction was evaluated in duplicate in at least two independent experiments. Data are 
presented as mean absorbance values  standard errors of the means (SEM) at 450 nm after removal of 
PBS negative-control absorbance values.
Enzyme immunoassay. An enzyme immunoassay (EIA) to determine the antigenic relationships of 
VLPs was conducted as previously described (53, 95). Briefly, Costar EIA plates (Corning) were coated with 
2 g/ml of VLPs from BtNoV, GI.1.Norwalk.1968, GII.4.Lordsdale.1997, GII.4.Sydney.2012, and MNV mixed 
with PBS for 4 h at room temperature and blocked overnight with blotto (5% instant dry milk–PBS–
Tween 20). Rabbit hyperimmune serum against GI and GII.4 HuNoVs was diluted 1:2 in blotto, added to 
each plate, and incubated for 1 h at  37°C. HRP-conjugated anti-rabbit secondary antibodies were diluted 
in blotto, added to each plate, and incubated for 30 min at 37°C. Negative controls included wells with 
no VLP and no primary antibody. Plates were developed with One-Step Ultra-TMB (Thermo Fisher) and 
2 M H2SO4 and read immediately at 450 nm. Plates were washed 3 times with PBS– 0.05% Tween 
between steps. Data are presented as mean absorbance   SEM at 450 nm after removal of negative-
FIG S1, TIF file, 0.2 MB.
TABLE S1, DOCX file, 0.01 MB.
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